Other studies using PDX models of bladder cancer have demonstrated that CD49f, in conjunction with surface antigens such as CD44, CK20, CD4714, and CD9015, discriminate poorly differentiated (basal) from differentiated bladder cancer cells. Here, CD44 is linked to urinary bladder carcinoma.